Press Releases

Media Focus

Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding

MEDIA FOCUS 

MEDIA FOCUS

Amidst Large Investment From Parent Company, Samsung Biologics Seeks to Ramp Up Biotech Funding

John Rim

President & CEO

 

During BIO 2022 in San Diego, John Rim, CEO and President of Samsung Biologics, discussed the company’s future investments as part of its roadmap for sustainable growth with Endpoints News.

 

Read more 

 

 MEDIA FOCUS

MEDIA FOCUS

Amidst Large Investment From Parent Company, Samsung Biologics Seeks to Ramp Up Biotech Funding

John Rim

President & CEO

 

During BIO 2022 in San Diego, John Rim, CEO and President of Samsung Biologics, discussed the company’s future investments as part of its roadmap for sustainable growth with Endpoints News.

 

Read more 

 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION